This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
covid-19 vaccine
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
What should middle market businesses consider in terms of a COVID-19 endemic future? Evaluating existing business models, updating policies and making investments in technology and digital infrastructure are just a few components. … READ MORE >
Understanding the rapid spread of COVID-19 variants
The emergence of COVID-19 variants is why the efficient and equitable distribution of vaccines across all nations is critical. … READ MORE >
5 things to know in life sciences: Week of March 8
This week we examine COVID-19 variants, heightened scrutiny on accelerated approval phase 4 confirmatory trials, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and more. … READ MORE >
Pandemic recovery signals new ways health care can serve and grow
Health care services are poised to lead the services recovery for the next two years, according to analysis from the UCLA Anderson School of Management. … READ MORE >
5 things to know in life sciences: Week of Feb. 22
In this week’s roundup we look at the latest news on Johnson & Johnson’s vaccine, a federal effort to expand genomic sequencing to track new COVID-19 variants, a major merger in the industry, and more.
… READ MORE >
5 things to know in life sciences: Week of Feb. 8
Recent industry news includes the impact of new COVID-19 variants on existing vaccines for the disease, the outlook for drug pricing reforms under the Biden administration, and the promise of 3D-printed hearts. … READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
Local facilities face logistical hurdles in maintaining the ultra-low storage temps needed for COVID-19 vaccines. This graphic shows how the vaccines from Pfizer, Moderna and Johnson & Johnson compare in terms of their storage requirements. … READ MORE >
5 things to know in life sciences: Week of Feb. 1
This week, we look at mRNA drug manufacturing capacity, gene therapy investments, news of a new FDA role dedicated to medical device cybersecurity, and more. … READ MORE >